Your browser doesn't support javascript.
loading
Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non-Small Cell Lung Cancer.
Planchard, David; Boyer, Michael J; Lee, Jong-Seok; Dechaphunkul, Arunee; Cheema, Parneet K; Takahashi, Toshiaki; Gray, Jhanelle E; Tiseo, Marcello; Ramalingam, Suresh S; Todd, Alexander; McKeown, Astrid; Rukazenkov, Yuri; Ohe, Yuichiro.
Afiliación
  • Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France. david.planchard@gustaveroussy.fr.
  • Boyer MJ; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
  • Lee JS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Dechaphunkul A; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Cheema PK; Faculty of Medicine and Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.
  • Gray JE; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia.
  • Todd A; Global Medicines Development, AstraZeneca, Cambridge, United Kingdom.
  • McKeown A; Global Medicines Development, AstraZeneca, Cambridge, United Kingdom.
  • Rukazenkov Y; Global Medicines Development, AstraZeneca, Cambridge, United Kingdom.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Clin Cancer Res ; 25(7): 2058-2063, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30659024

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia